Formosa Laboratories Inc
TWSE:4746
Formosa Laboratories Inc
Deferred Income Tax
Formosa Laboratories Inc
Deferred Income Tax Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Deferred Income Tax
NT$21m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
1%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Deferred Income Tax
NT$468m
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Deferred Income Tax
NT$1.3m
|
CAGR 3-Years
55%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-8%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Deferred Income Tax
NT$104.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
68%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Deferred Income Tax
NT$1.1B
|
CAGR 3-Years
53%
|
CAGR 5-Years
45%
|
CAGR 10-Years
10%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Deferred Income Tax
NT$85.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
See Also
What is Formosa Laboratories Inc's Deferred Income Tax?
Deferred Income Tax
21m
TWD
Based on the financial report for Dec 31, 2024, Formosa Laboratories Inc's Deferred Income Tax amounts to 21m TWD.
What is Formosa Laboratories Inc's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
1%
Over the last year, the Deferred Income Tax growth was -14%. The average annual Deferred Income Tax growth rates for Formosa Laboratories Inc have been -4% over the past three years , -3% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet